Werfel, T., Heratizadeh, A., Augustin, M., Bangert, C., Bauer, A., Biedermann, T., Brans, R., Domröse, N., Gieler, U., Gießler-Fichtner, O., Hamelmann, E., Hampe, S., Heuer, R., Kahle, J., Kinberger, M., Koch, M., Köhler, M., Legat, F., Nemat, K., Neustädter, I., Peters, E.M.J., Radonjic-Hoesli, S., Reese, I., Schmid-Grendelmeier, P., Schmidt-Göhrich, U.-K., Schmitt, J., Schnopp, C., Schwennesen, T., Simon, D., Stamos, K., Termeer, C., Treudler, R., von Kiedrowski, R., Wagner, I., Waßmann-Otto, A., Weckmann, G., Werner, R.N., Wollenberg, A., Worm, M. & Ott, H. (2026). Update of the evidence-and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation. Allergologie , 49(6), 275-300. Dustri. doi:10.5414/ALX02638E.